Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes

NCT04239586 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Maturity-Onset Diabetes of the Young, Type 3
Maturity Onset Diabetes of the Young, Type 1
Childhood Diabetes Mellitus
Insulin-dependent Diabetes Mellitus

Interventions

DRUG: Sulfonylurea

Sponsor

Haukeland University Hospital